© 2020 MJH Life Sciences™ and Neurology Live. All rights reserved.
Dementia and Alzheimer Disease
Blarcamesine Safe in Phase 2 Parkinson Disease Dementia Study
October 29, 2020
Article
The company is planning a pivotal trial of blarcamesine in Parkinson disease dementia after submitting results of the phase 2 study to the FDA for regulatory guidance.
Joe Verghese, MBBS, MS: Characteristics of Motoric Cognitive Risk Syndrome
October 29, 2020
Video
The director of the Montefiore Einstein Center for the Aging Brain detailed the symptoms of motoric cognitive risk syndrome and how they compare to more typical mild cognitive impairment.
Alzheimer Disease Crossroads: Why a One-Way Approach to Treatment, Prevention May Be Futile
October 27, 2020
Article
Constantino Iadecola, MD, discusses the interaction of vascular risk factors and the shortcomings of our current clinical approach to Alzheimer disease.
NeurologyLive Friday 5 — October 23, 2020
October 23, 2020
Article
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 23, 2020.
Amyloid ß and Tau Pathology Linked to Dementia With Lewy Bodies Phenotype
October 22, 2020
Article
The findings of this multicenter cohort may have implications for diagnosis, prognosis, and disease monitoring, as well as for clinical trials targeting disease-specific proteins in DLB.